[Common name] Premixed Protamine Recombinant Human Insulin Injection (30/70)

[Ingredients] This product is composed of 30% recombinant human insulin injection and 70% protamine recombinant human insulin injection.

[Indication] It is indicated for diabetes.

[Specification] 3ml：300 international units (10.5mg), (pen core)

[Usage and Dosage] This product is a kind of dual phase insulin preparation. Its dual phase composition includes short-acting insulin and intermediate-acting insulin. When fast-acting and prolonged effectiveness is required, mixed insulin may be generally rendered once or twice a day. For subcutaneous injection, the dosage shall be decided by the doctor depending on the condition of disease.

[Package] Pen core is made of type 1 glass, including brombutyl rubber piston and brombutyl/polyisoprene rubber membrane. The glass bean inside pen core facilitates repetitive mixing of insulin. 1 pcs/bottle.

[Expiry Date] 24 months

[Executive Standard]State Food and Drug Administration, Standard YBS00542010

[Approval Document Number] G (J) S20100013